RecruitingNCT05239858
International Wilson's Disease Patient Registry (iWilson Registry)
Sponsor
Orphalan
Enrollment
500 participants
Start Date
Jun 29, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Longitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected from the diagnostic evaluation and any relevant past medical history and a summary of WD medication history.
Eligibility
Min Age: 12 Years
Inclusion Criteria6
- Patient is able to provide, and has provided, written informed consent/assent
- Written documentation has been obtained in accordance with the relevant country and local privacy requirements, where applicable, including:
- For US sites: Authorization for Use and Release of Health Research Study Information
- For EU sites: Data Protection Consent
- All patients diagnosed with WD including pre-symptomatic individuals and individuals with co-morbidities/diagnoses
- Any treatments including prescribed and homeopathic/traditional therapies or naive patients on no therapy
Exclusion Criteria1
- \. Refusal of informed consent by either patient or their legally acceptable guardian
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05239858